PROTHENA CORPORATION PUBLIC LIMITED COMPANY
Income Statement
| Line Item | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 |
|---|---|---|---|---|---|---|
| Revenue | $27.5M | $1.1M | $1.6M | $50.9M | $676.0K | $2.7M |
| Cost of Revenue | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — |
| Gross Margin | — | — | — | — | — | — |
| Operating Expenses | ||||||
| Research & Development | $134.5M | $119.5M | $58.4M | $38.5M | $26.1M | $34.1M |
| SG&A Expense | $48.2M | $41.1M | $23.1M | $19.1M | $15.1M | $9.9M |
| Operating Income | $-155.3M | $-159.5M | $-79.9M | $-6.6M | $-40.4M | $-41.4M |
| Operating Margin | -564.2% | -15,121.8% | -4,974.3% | -13.1% | -5,980.3% | -1,557.9% |
| Interest Expense | — | — | — | — | — | — |
| Pretax Income | $-157.6M | $-159.0M | $-79.9M | $-6.3M | $-40.6M | $-41.4M |
| Income Tax Expense | $-4.4M | $1.1M | $701.0K | $811.0K | $415.0K | $6.0K |
| Net Income | $-153.2M | $-160.1M | $-80.6M | $-7.2M | $-41.0M | $-41.4M |
| Net Margin | -556.8% | -15,176.1% | -5,016.3% | -14.1% | -6,064.5% | -1,558.0% |
| EPS (Basic) | $-4.07 | $-4.66 | $-2.66 | $-0.29 | $-2.20 | $-2.84 |
| EPS (Diluted) | $-4.07 | $-4.66 | $-2.66 | $-0.29 | $-2.20 | $-2.84 |
| Shares Outstanding (Basic) | 38.5M | 34.8M | 31.7M | 27.4M | 21.9M | 17.7M |
| Shares Outstanding (Diluted) | 38.5M | 34.8M | 31.7M | 27.4M | 21.9M | 17.7M |
| Dividends Per Share | — | — | — | — | — | — |